Travoprost
Izba, Travatan, Travatan Z (travoprost) is a small molecule pharmaceutical. Travoprost was first approved as Izba on 2001-03-16. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. Travatan z's patents are valid until 2029-10-13 (FDA).
| Trade Name | Izba, Travatan |
|---|---|
| Common Name | Travoprost |
| Indication | ocular hypertension, open-angle glaucoma |
| Drug Class | Prostaglandins |
